Physician profile
Keyur Modi
NPI 1255869616
$1,389.72
in general payments reported to CMS, 2019-2025
10 companies · $17.19 in 2025
The $17.19 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $16.09 · 2023: $782 · 2024: $450 · 2025: $17.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $800 · Food and Beverage: $372 · Education: $77.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $800.00 |
| Food and Beverage | $371.54 |
| Education | $77.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $800.00 | 2023-2024 | |
| Novo Nordisk INC | $124.41 | 2021 | |
| Straumann USA LLC | $105.49 | 2022-2023 | |
| Zimvie INC. | $105.45 | 2024 | |
| Nobel Biocare USA | $89.55 | 2023 | Nobelactive |
| Kerr Corporation | $89.55 | 2023 | Tf |
| Dentsply Sirona INC | $31.18 | 2024-2025 | Primescan Connect, Orthophos E |
| Septodont INC. | $15.18 | 2024 | Biodentine |
| Orapharma, A Division of Bausch Health US, LLC | $14.93 | 2024 | Arestin |
| 3m Company | $13.98 | 2023 | 3m Espe Filtek Supreme Ultra Universal Restorative, Scotchbond Universal Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyur Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.